Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Aytu Bioscience
68,7
%
| 61 | 63,2 % | 74 | 68,7 % | +20,74 % |
Aytu Consumer Health
31,3
%
| 36 | 36,8 % | 34 | 31,3 % | -5,48 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
99,6
%
| 95 | 97,9 % | 107 | 99,6 % | +13,01 % |
International
0,4
%
| 2 | 2,1 % | 0 | 0,4 % | -76,68 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16/04/15 |
Jarrett Disbrow
FOU | Founder | 49 | 16/04/15 |
Mark Oki
DFI | Director of Finance/CFO | 55 | 17/01/22 |
Margaret Cabano
COO | Chief Operating Officer | - | 01/01/05 |
Russell McMahen
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Greg Pyszczymuka
PRN | Corporate Officer/Principal | - | - |
Suzane Kennedy
LAW | General Counsel | - | 01/06/18 |
Ryan J. Selhorn
PRN | Corporate Officer/Principal | 42 | - |
Victoria Cordova
HRO | Human Resources Officer | - | 01/03/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Vivian Liu
BRD | Director/Board Member | 62 | 01/07/22 |
Jarrett Disbrow
FOU | Founder | 49 | 16/04/15 |
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16/04/15 |
John Donofrio
BRD | Director/Board Member | 56 | 12/07/16 |
Carl Dockery
BRD | Director/Board Member | 61 | 13/04/16 |
Abhinav Jain
BRD | Director/Board Member | 33 | 12/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 568 075 | 5 373 388 ( 96,50 %) | 0 | 96,50 % |
Información de la empresa
Aytu Biopharma, Inc.
7900 East Union Avenue Suite 920
80237, Englewood
+720 437 6580
http://www.aytubio.comVentas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,26 % | 682 mil M | |
+30,81 % | 586 mil M | |
-2,95 % | 364 mil M | |
+17,78 % | 327 mil M | |
+4,10 % | 285 mil M | |
+16,26 % | 240 mil M | |
+9,91 % | 209 mil M | |
-8,34 % | 203 mil M | |
+7,96 % | 165 mil M |